Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
64.08
-1.92 (-2.91%)
At close: Jun 16, 2025, 4:00 PM
64.09
+0.01 (0.02%)
After-hours: Jun 16, 2025, 4:00 PM EDT
Arcellx Market Cap
Arcellx has a market cap or net worth of $3.53 billion as of June 16, 2025. Its market cap has increased by 30.85% in one year.
Market Cap
3.53B
Enterprise Value
3.02B
1-Year Change
30.85%
Ranking
Category
Stock Price
$64.08
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $3.53B, an increase of 601.93%. That is a compound annual growth rate of 78.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 3.64B | -12.30% |
| Dec 31, 2024 | 4.15B | 43.89% |
| Dec 29, 2023 | 2.88B | 112.13% |
| Dec 30, 2022 | 1.36B | 170.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| Regencell Bioscience Holdings | 294.27B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |